Limited coverage criteria – febuxostat

Last updated on March 17, 2025

Special Authority requests can now be submitted online. It's simple and quick!

Generic name	febuxostat
Strength & form	80 mg tablet

Special Authority criteria	Approval period
For the reduction of serum uric acid levels in patients with gout who demonstrate immune-mediated hypersensitivity to allopurinol	Indefinite

Practitioner exemptions

None

Special notes

Details regarding a patient’s immune-mediated hypersensitivity reaction to allopurinol is required

Special Authority request form(s)

Log in to eForms
HLTH 5328 – General Special Authority request (PDF, 656KB)

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics

Limited coverage criteria – febuxostat

Generic name

Strength & form

Special Authority criteria

Approval period

Practitioner exemptions

Special notes

Special Authority request form(s)